Matthew HG Katz, MD
University Of Texas, M.D. Anderson Cancer Center, Houston
Katz is an associate professor in the department of Surgical Oncology at the University of Texas M.D. Anderson Cancer Center. His clinical and research interests focus on patients with pancreatic cancer. He has extensive experience in the design and conduct of clinical trials and is currently the national principal investigator for an intergroup cooperative group study of the effects of preoperative therapy on patients with advanced pancreatic cancer.
He has published more than 90 articles that have described novel multi-modality treatment approaches for patients with this disease. He maintains a pancreatic surgery clinical practice.
RESEARCH FUNDED BY SKY FOUNDATION, INC.
PROJECT TITLE: PREOPERATIVE THERAPY NATIONAL CLINICAL TRIAL
Matthew HG Katz, M.D., Chief, Pancreatic Surgery Service, Vice Chair for Research, Department of Surgical Oncology, The University of Texas MD Anderson Medical Cancer Center
Alliance A021501 was a national clinical trial of preoperative therapy for patients with advanced pancreatic cancer
Patients with borderline resectable pancreatic cancer were randomly selected to receive either systemic chemotherapy or chemotherapy plus radiation therapy prior to anticipated surgical resection
Sky Foundation funds were utilized by clinicians to perform central radiologic and pathologic evaluation of each patient, enabling robust assessment of treatment response
The trial met its accrual goal earlier than anticipated, and the data are maturing
Results from this clinical trial will be presented in the next couple of years